From Cells to Circuits: The New Era of Bioelectronic Precision Medicine

The seamless integration of biology with modern electronics is redefining how we study, diagnose, and treat disease. In this new era of bioelectronic precision medicine, advances in two-dimensional (2D) materials such as graphene are enabling direct electronic interfaces with biological molecules, cells, and tissues, transforming the way we decode and control life’s processes. Dr. Kiana Aran will present how her lab is harnessing these innovations to develop next-generation genotyping and gene-editing quality control platforms, accelerating pandemic preparedness and ensuring the safety and reliability of CRISPR-based therapeutics.

Beyond molecular sensing, the integration of bioelectronics with organ-on-chip systems opens a powerful window into complex human biology. Dr. Aran will discuss how electronic - biological hybrid models of the brain-on-chip and blood-brain interface are shedding light on the molecular and biophysical mechanisms linking blood aging to neurodegeneration. Together, these technologies chart a path toward real-time, multiplexed, and personalized monitoring of human health, bridging cells to circuits and biology to technology in pursuit of more predictive, preventive, and equitable medicine.